BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
17 results:

  • 1. Coexisting Papillary and Anaplastic Thyroid cancer: Elucidating the Spectrum of Aggressive Behavior.
    Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
    Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis.
    Yin L; Hou S; Hou LL; Pu CC
    Endocrine; 2023 Feb; 79(2):331-341. PubMed ID: 36207552
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
    Chen J; Chen S; Dai X; Ma L; Chen Y; Bian W; Sun Y
    Front Immunol; 2022; 13():1007326. PubMed ID: 36189254
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
    Yamakawa K; Koyanagi-Aoi M; Uehara K; Masuda A; Yanagimoto H; Toyama H; Fukumoto T; Kodama Y; Aoi T
    PLoS One; 2022; 17(5):e0266620. PubMed ID: 35617311
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
    Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
    J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive Analysis of Tripterine Anti-Ovarian cancer Effects Using Weighted Gene Co-Expression Network Analysis and Molecular Docking.
    Long X; Liu L; Zhao Q; Xu X; Liu P; Zhang G; Lin J
    Med Sci Monit; 2022 Jan; 28():e932139. PubMed ID: 35022380
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and prognosis of Patients with Testicular Germ Cell Tumors.
    Olcucu MT; Karamik K; Yilmaz K; Okuducu Y; Cakir S; Ates M
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):1041-1046. PubMed ID: 33143824
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The cancer Genome Atlas (TCGA) Database.
    Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
    Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor runx1t1.
    Sun T; Yang P; Gao Y
    Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
    Yan B; Hou Y; Chen D; He J; Jiang Y
    Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression Patterns of Nrf2 and Keap1 in Ovarian cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
    Cho HY; Kim K; Kim YB; Kim H; No JH
    Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis.
    Hu GY; Tao F; Wang W; Ji KW
    World J Surg Oncol; 2016 Mar; 14():82. PubMed ID: 26969625
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer.
    Shim SH; Kim DY; Seo MJ; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Oct; 23(8):1383-92. PubMed ID: 24257552
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Abnormal expressions of positive cell cycle control factors and thyroid carcinoma occurrence and progression].
    Shi L; Zhang A; Luo Y; Zhao S; Tian H; Yang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1031-5. PubMed ID: 23895847
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
    Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
    Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.